Investigations
121 stories · Page 2 of 6
Physics of Fluids Sent a Postdoc's Name to the Authors Whose Algebra He Flagged
AIP Publishing tells its editors to protect the anonymity of anyone raising a concern. Physics of Fluids sent a postdoc's name, institution and rank to the authors he challenged, and 8 referees later found nothing to defend in their paper.
InvestigationsIn Cancer Alley, the Most Polluted Air Came With More Than Four Times the Odds of a Newborn Heart Defect
Among Louisiana mothers without private insurance, the heaviest modeled industrial air toxics tracked with 4.29 times the odds of a baby born with a heart defect. The scientist who led the work says Tulane gagged her pollution research.
InvestigationsThe HeartMate 3 Won Its Market on a Low Stroke Count. The Neurologic Events It Left Off Are Just as Common.
Eight percent of HeartMate 3 patients have a stroke. Another 8 percent have a seizure, a transient ischemic attack, or a brain bleed its headline safety score never tallied, and two-year survival in those patients runs as low as 45 percent.
InvestigationsIn Pfizer's Pivotal Trial, a Volunteer's Pericarditis Became a 'Suspected COVID' Case That Counted Against No One
The only Argentine site in Pfizer's pivotal trial was run by the same doctor who authored the results, and when a 35-year-old developed pericarditis after his second dose, the records moved the episode off the vaccine's ledger.
InvestigationsThe Mandatory Drug-Pricing Rule Nearly Every Major Drugmaker Was Allowed to Skip
Medicare's actuaries scored the final rule at $440 million in savings. The proposal they started with was worth $12 billion.
InvestigationsThe FDA Is Recruiting New Advisers Without Publishing the Rule for Who's Too Conflicted to Sit
Acting commissioner Kyle Diamantas is inviting scientists and 'consumer voices' onto the FDA's advisory panels. The agency has never published how it decides which of them carries a disqualifying conflict, thirteen years after Congress ordered it to.
InvestigationsThe MAHA Summit Charged Corporations Up to $300,000 for a Seat Beside the Officials Who Regulate Them
UnitedHealth got a panel. Grail, whose cancer test sat before the FDA, helped foot the bill. The regenerative ranchers and pesticide experts were nowhere on the program.
InvestigationsFor Five Years This Nurse-Led Florida Clinic Was a Federal 'Look-Alike.' Now It's Wired Into the Real Machine.
A West Palm Beach clinic run by nursing faculty, nurse practitioners, and their students spent five years as a federal 'look-alike.' Funded status adds a $650,000 grant, federal malpractice cover, and loan backing on top of the deep 340B drug discounts and sliding-scale mandate it already ran on.
InvestigationsThe Fraud Hunter Says She Can No Longer Tell Fake Science From Real
Journals retracted more than 10,000 papers in a single year. In one test, 2 of 3 biomedical experts could not tell AI-fabricated images from real ones, and Elisabeth Bik, the field's most relentless fraud hunter, says peer review is not prepared.
InvestigationsThe FDA Will Now Accept Real-World Evidence for Devices Without the Patient Records Behind It
The curation that turns raw medical charts into "regulatory-grade" evidence happens inside private vendors like Roche-owned Flatiron Health. The public record does not show who, if anyone, independently audits it.
InvestigationsA Memphis Team Linked Tap-Water Fluoride to Kids' Testosterone, Sodium, and Uric Acid
In 4,470 American children, each unit of predicted plasma fluoride from tap water tracked with a testosterone geometric mean ratio of 0.49, plus higher serum sodium and uric acid. The authors declared no external funding.
InvestigationsKennedy's Ultra-Processed Food Rule Leaves Open the Loophole He Promised to Close
In February he vowed to act on the petition that demanded real safety review of food additives. In August his FDA proposed a rule that still lets companies certify their own chemicals as safe, and sell them before anyone at the agency looks.
InvestigationsBritain Is Building a National Genetic Screening Service on Scores That Miss Nine of Every Ten Cases
In 2019 the same company's test convinced a health secretary he might die of prostate cancer. He was near average. Now its scores are heading into a biobank of five million Britons and the NHS's new prevention service.
InvestigationsThe Fibroid Procedure That Spares the Uterus: Its Best Head-to-Head Evidence Was Paid For by the Device Maker
Radiofrequency ablation matched myomectomy on two-year symptom relief in a randomized trial. The device maker paid for that trial, and the durability question it cannot answer is the one that matters most.
InvestigationsA Warehouse Stored Infant Formula Among 26 Rodents. After 32 Inspections, No One Was Charged.
The FDA found infant formula stored among 26 rodents at a Minneapolis warehouse the state had inspected 26 times since 2013. The remedy was a cleanup order and no charges, the same month the Justice Department let Abbott pay nearly $385 million and close its own formula criminal case with no one cha
InvestigationsThe WHO Halted a Global Drug Trial on Data a Tiny Company Would Not Let Auditors See
Ninety-six thousand patients across six continents, supplied by a Chicago firm that would not open its database to independent auditors, and the WHO changed course in days.
InvestigationsThe Study Being Used to Close the Vaccine-Death Question Can't Rule Out Zero Excess Deaths in New Zealand
New Zealand's headline pandemic death study was co-authored by one of the country's most visible COVID modellers, and its four-year estimate runs from 1,134 fewer deaths than expected to 2,927 more. The modellers are calling it settled.
InvestigationsBrain on Fire: Ottawa's Vaccine-Injury Program Spent More on Its Contractor Than on the Injured
Fifty injured Canadians testified in Ottawa over four days, and Health Canada did not show. The compensation program has spent more on its contractor's overhead than on the people it was built to pay.
InvestigationsThe Ebola Vaccine 2,000 Congolese Frontline Workers Received Isn't Known to Work on the Strain Killing Them
Bundibugyo Ebola has no licensed vaccine, so the response is dosing frontline workers with Ervebo, approved only against a different strain, while the State Department fast-tracks $50 million to CEPI and a four-candidate portfolio that includes Moderna, in an outbreak the surveillance system missed
InvestigationsThey Called It GoodBrother: Four Years of Teaching the Elderly to Accept Cameras in Their Homes
The project's own charter says the aim is to 'increase user acceptance' of audio and video monitoring in the homes of older and frail people. On World Patient Safety Day, they call that safety.
InvestigationsFifty Sworn Witnesses, 1,400 Who Applied, and Not One Official From Health Canada
A sitting MP put Canadians who say the COVID shots injured them under oath on Parliament Hill. Health Canada, which authorized the products and tracks their harms, sent no one.
InvestigationsAn 'A' for the Air Outside, Nearly Three Times Dirtier Inside
The EPA rated one Virginia region's outdoor air a clean 'A.' Inside the public-housing apartments of elderly and disabled residents, fine-particle pollution ran nearly three times higher, the air most long-term pollution studies miss.
InvestigationsThe Last Time Moderna's Stock Soared on Vaccine News, Insiders Sold $400 Million. It's Happening Again.
Moderna's stock has run up 137 percent in a month on a melanoma-vaccine trial that has not released its detailed data or reported overall survival. As retail chased the rally, the CEO sold $28.7 million in shares two weeks before the readout, and the rest of the C-suite cashed out after the stock tr
InvestigationsThe Sixteen Drug Companies Funding Britain's Biggest Health Study Can Mine Data Its Own Scientists Say Skews Rich and Healthy
Our Future Health signed up 1.9 million volunteers on £354 million of public money and £180 million from 16 drug companies. Its own scientists now warn the sample skews wealthy and healthy, and cannot yet say how common any disease actually is.